Brief: Heat Biologics Entered Into Collaboration With University Of Miami To Develop A Coronavirus COVID-19 Point-Of-Care Diagnostic Test
23/03/2020 12:29
March 23 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS INC - ENTERED INTO COLLABORATION WITH
UNIVERSITY
OF MIAMI TO DEVELOP A CORONAVIRUS COVID-19 POINT-OF-CARE
DIAGNOSTIC TEST
* HEAT BIOLOGICS INC - DIAGNOSTIC TEST DESIGNED TO DELIVER
RESULTS
ON A PAPER STRIP IN UNDER 30 MINUTES.
Source: (https://bit.ly/2wmOf13)
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company